• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; Ventricular (assist) bypass

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; Ventricular (assist) bypass Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Stroke/CVA (1770); Hemorrhage/Bleeding (1888); Unspecified Infection (1930); Heart Failure/Congestive Heart Failure (4446)
Event Date 04/01/2023
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between the heartmate (hm) 3 left ventricular assist system (lvas) and the reported events could not be conclusively determined through this investigation.The heartmate 3 device serial numbers and other specific case/patient information are not available and were not requested.No product was evaluated under this complaint.The heartmate 3 (hm3) left ventricular assist system (lvas) instructions for use (ifu), rev.C, is currently available.Section 1 of this ifu lists right heart failure, stroke, bleeding, infection, and cardiac arrhythmia as adverse events that may be associated with the use of the heartmate 3 left ventricular assist system.Section 6, ¿patient care and management¿ (under ¿right heart failure), states that patients may develop right ventricular failure during or shortly after implant and outlines the associated treatment options.Section 6 (under ¿caution!¿) further explains that right ventricular dysfunction, especially when combined with elevated pulmonary vascular resistance, may limit the effectiveness of the left ventricular assist system due to reduced filling of the pump.Section 6 (under "anticoagulation") also outlines the recommended anticoagulation regimen (including inr range) for patients using the heartmate 3 lvas, as well as the suggested anticoagulation modifications in the event that there is a risk of bleeding.Additionally, section 6 lists arrhythmia as a potential late postimplant complication that may be associated with the use of heartmate 3 lvas.Care instructions in regard to preventing infection are provided in various sections of the ifu, including caring for the driveline exit site and controlling infection.The heartmate 3 lvas patient handbook, rev.D, also contains information about caring for the driveline and preventing infection.The serial numbers or other identifying information of the products were not reported and were not able to be determined during the investigation.No further information was provided.The manufacturer is closing the file on this event.
 
Event Description
Related mfr # 2916596-2024-01786.It was reported through the research article ¿the impact of small left ventricular dimension on outcomes after heartmate 3 lvad implantation¿ that the heartmate 3 (hm3) device may be associated with right heart failure, stroke, bleeding, infection, arrhythmia.This retrospective study compared 2-year survival and adverse events of the 1921 patients implanted with hm3 devices within the momentum 3 trial portfolio.The patients were compared based on the presence or absence of a left ventricular end diastolic diameter (lvedd) of < 55 mm (millimeters).Of the 1921 patients, 108 had lvedd < 55mm, and 1813 had lvedd >= 55mm.Instances of right heart failure were greater in the smaller lvedd group (41.7 vs.36.9%; p= 0.03).The need for right ventricular mechanical support, stroke, bleeding, infections, and arrhythmias were reported to have similar rates between the two groups.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
Ventricular (assist) bypass
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
lindsey sallese
6035 stoneridge drive
pleasanton, CA 94588
7818528207
MDR Report Key19005536
MDR Text Key338942824
Report Number2916596-2024-01785
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public813024013297
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/29/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number106524US
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received03/18/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-